Clinical trial
Benralizumab Airway Remodeling Study in Severe Eosinophilic Asthmatics
NCT03953300
Study timeline
Study start (actual)2019-10-08Date precision: day
Registry last updated2026-09-25
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Asthmaunresolved
Interventions
BenralizumabBIOLOGICAL
PlaceboBIOLOGICAL
Sponsors & collaborators
AstraZenecalead sponsor
Mapped research locations
Los AngelesCalifornia, United States1St LouisMissouri, United States1MiamiFlorida, United States1LondonUnited Kingdom1PittsburghPennsylvania, United States1BirminghamAlabama, United States1IndianapolisIndiana, United States1JacksonvilleFlorida, United States1Ann ArborMichigan, United States1RochesterMinnesota, United States1Winston-SalemNorth Carolina, United States1CalgaryAlberta, Canada1
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT03953300 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.